ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

RBGP Rbg Holdings Plc

8.85
0.00 (0.00%)
18 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Rbg Holdings Plc LSE:RBGP London Ordinary Share GB00BFM6WL52 ORD GBP0.002
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 8.85 8.70 9.00 8.85 8.85 8.85 40,695 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Business Services, Nec 54.13M 4.2M 0.0441 2.01 8.44M
Rbg Holdings Plc is listed in the Business Services sector of the London Stock Exchange with ticker RBGP. The last closing price for Rbg was 8.85p. Over the last year, Rbg shares have traded in a share price range of 8.65p to 55.00p.

Rbg currently has 95,331,236 shares in issue. The market capitalisation of Rbg is £8.44 million. Rbg has a price to earnings ratio (PE ratio) of 2.01.

Rbg Share Discussion Threads

Showing 1526 to 1549 of 1550 messages
Chat Pages: 62  61  60  59  58  57  56  55  54  53  52  51  Older
DateSubjectAuthorDiscuss
12/3/2024
11:23
Surprised they raised even that much in the retail offer, why would you bother at that price which was no better than market rate?
mrphil
11/3/2024
08:50
It's been turning since £1. Not sure I believe it
tradingcoder
11/3/2024
07:07
1. Retail Offer announced to raise up to £700,000

2. Amount raised £137,910


-One can draw one's own conclusions as to the success or otherwise of the Retail Offer.

-Speaks to the current Retail appetite for the shares.


all imo. dyor.
qp

quepassa
03/3/2024
21:06
The tide is turning here. Think I will take a punt soon.
scepticalinvestor
26/2/2024
15:41
RBG will not get £10m for Convex even from Convex, their best chance. Excellently run company with long term prospects and bought for a fair £22m price at the time, but the M&A business is now dead. Any sale will be affected by their now onerous office lease too.

Can it be sold to anyone else? Unlikely.
Will the retail share issue succeed without production of audited FY 2023 accounts? No.
Were shareholders told that the HSBC recent support included a ‘holiday’; for interest payments from Jan 24 to June 24? No. It will have to be paid.

tomtrudgian
22/2/2024
08:40
Doesn't seem like a good time to sell Convex capital at the absolute bottom of the cycle . Gonna end up buying it from management at 22 million and selling it back to them for 10
nchanning
14/2/2024
22:50
Convex is pleased to have advised the shareholders of TRM Nutrition | Animal Health, the market-leading Irish company specialised in the development of high-quality nutritional supplements for horses, on their sale to the Equine Care Group (backed by Bencis), Europe's leading group of specialist equine hospitals and clinics. We are very excited to see the new partnership flourish.  Congratulations to the team involved in this exciting acquisition: James Edge, Isaac Asamoah, Inderjeet Sauari, Harriet Shaw, and Jay Crowney. If you want to learn more about this deal, please follow the link: https://lnkd.in/evk-p7_W
aeonflux
14/2/2024
22:49
Some updates from Convex...Convex is proud to have advised the shareholders of Metallisation Ltd, a global leader in the thermal spray industry, on their sale to Kymera International (backed by Palladium Equity Partners, LLC). We wish both parties all the best in their new partnership and are excited to see what it brings in the future. Congratulations to the team involved in this successful deal: James Edge, Isaac Asamoah, Oliver Hennessy, Daniel J Shaw, Harriet Shaw, Cameron Rushton, and Jay Crowney. If you want to learn more about this exciting acquisition, please follow the link: https://lnkd.in/gpi7AXKS
aeonflux
30/1/2024
12:59
Haven't been on here for a while. I recall a lot of posters thinking that random journo at IC tipping this could do no wrong with his crystal ball. Did try to urge caution.
tradingcoder
15/1/2024
14:44
Chart of horrors this! I was lucky to sell and escape this with a small loss, stops and charts guys :)
jonny_wright
23/12/2023
19:59
The end is nigh unfortunately.
shep22
22/12/2023
07:47
Headline of Law Society Gazette article dd 18/12/23:-


"Law firm owner's shares in freefall after grim profit warning".



Link to article below

hXXps://www.lawgazette.co.uk/news/law-firm-owners-shares-in-freefall-after-grim-profit-warning/5118232.article



Also another article dated 11/12/23 in same gazette which finishes by illustrating the yearly performance of shares in the Company.


ALL IMO. DYOR.
QP

quepassa
21/12/2023
14:34
A new RBG Debenture was registered 13 Dec 23. Didn’t know? It should under AIM rules have been disclosed, but were not. Read the 40 pages at Companies House.

Some posters think Registered Debentures are a bit like loans, with both a percentage rate and expiry date. No, Registered Debentures need neither.

tomtrudgian
20/12/2023
19:31
This does like it's going to zero unfortunately. If they start struggling to keep staff and clients, and with a ton of debt, it's difficult to see how they escape. Shame as it looked quite a promising story a few years ago. The lesson here is stick to your core strength and don't try to diversify into all these untested areas.
riverman77
20/12/2023
18:51
Couldn't see much future here so got out today taking my loss with me. At least I have a small residue to invest in more promising opportunities that I see on the horizon.
GLA

ptgint
19/12/2023
11:47
Thanks for your intelligent post, Shep22. There are now as often ‘bottom feeders’, trying quite reasonably to reduce the average cost of their holdings, but is the RPG price at the bottom? Not quite.

The principle concern is surely staff retention and RBG reputation amongst clients. The bank covenants may or may not be in breach, but that is fairly unimportant given the lack of easily realisable assets, and therefore HSBC action so RBG still have a little time.

The as yet unexplained attempt to assign (sell) office leases may be impossible without cost. In any event RBG will still be on the hook for the remaining lease length, should the assignee fail to pay the rent, and negotiations will be drawn out. The alleged lack of RNS transparency is frankly just what many managements would do to help the loan facility extension and therefore share price.

Has not worked so far, but a ‘white knight’ takeover is not entirely impossible. So too is a rights issue, but both would nearly wipe out shareholders. The likely conclusion is that nothing affordable can be done, and RBG shares will be low for very many years. Then some like me may buy back in.

All very sad, and not 100% the fault of Nicola Foulston. My subscription to the law society’s gazette has constant reports of both lawyers and barristers, large and small, in difficulty.

tomtrudgian
18/12/2023
21:31
I have taken a lot of criticism from individuals associated with RBG because of my postings over the past while,it has been alleged that I have an axe to grind. Yes, that is partly true, I have an issue with the company's management withholding information and in some cases misleading shareholders. As recently as 28 of September the CEO issued a statement to the effect the company was performing in accordance with guidance. This was untrue and he was aware of that. However, it did not begin there, the company has mislead shareholders at various times over the past three years at least. It is also the case the original prospectus contained misstatements. It now seems to me that the company is in breach of its banking covenants if one applies the updated performance figures to the balance sheet. The position is now perilous, it gives me no satisfaction that I have been proven right.
shep22
18/12/2023
10:56
Lawrence Hulse of Dowgate Wealth discusses RBGP @ 56:55
cottoner
18/12/2023
09:59
So, the £6.5m term loan expires in just two years. That will however enable the auditors to state that RPG is a ‘going concern’ in their 2023 audit report.

The office leases are up for assignment, which may not be possible in today’s market without payment of a reverse premium.

At last RBG now confirm that the total interest rate is increased to 8.3%, not ‘unchangedR17; as previously said.

New adverse employment case decisions. No Memory Crystal or Convex deals now expected. Bad debts up.

How many are still holding RBG shares apart from Ian Rosenblatt, whose shares are both mortgaged and well under water?

The only good news is that HSBC cannot now foreclose without losing it all. So RBG may survive in some form, as continuing shareholders will be hoping.

tomtrudgian
18/12/2023
09:14
Indeed.




This however is what the CEO wrote in the 28/9/23 RNS - less than three months ago:-

"As a result, the Board is confident that the core Legal Services business will meet its full year expectations. Convex Capital has grown its pipeline to 22 deals over the past few months, seven of which are in the latter stages of completion. We are confident that several of these deals will complete before the end of the year. The Board therefore expects to achieve full-year market forecast."


all imo. dyor.
qp

quepassa
18/12/2023
08:55
Note that there's no comment from the CEO Jon Divers. Is he about to go?
scubadiverr
11/12/2023
16:37
Take the trouble to read the new 40 page debenture. It was registered under RBG Holdings Ltd (and includes Convex Capital, Convex Holdings, RBL legal services and RB Law) on 3 Nov 23 at Companies House. It is free to read.

There is no maturity and, clause 18, the security extends until satisfied. Strictly speaking the facility can be withdrawn immediately if the conditions are not met. That is entirely standard, and applies to all overdrafts, mortgages etc.

Not at all, adeg, I have queried the ‘2.4% - 3.15%’ with SEC Newgate, RBG’s appointed financial PR advisors, and their reply today was that the entire facility margin above SONIA was 3.15% due to covenants as to the large extent of the facility drawn down, ie 8.3% variable currently.

If the intangible assets are written down that will have no effect on either cash flow or future trading. I agree that Corporation Tax payment in respect of 2023 is wholly unlikely. I agree that tax losses can often be recoverable against future profits.

Oh, and I have not been an auditor for 45 years. Since then I have employed auditors at my three modest but successful companies before retiring.

It remains grossly misleading for the RBG RNS to state that ‘the interest rate on the renewed facility will remain the same as for the previous facilities’. However the future success of RBG is entirely probable.

tomtrudgian
11/12/2023
14:05
The relatively short two year maturity of the new facility is to be noted.

all imo. dyor.
qp

quepassa
11/12/2023
12:56
Banking facility agreed £24.5 million minus current debt position at the 8th December of £22.6 million equals £1.9 million of headroom.

Yes there will be expenses and income that will mean this figure moves, including the interest payments and the loan repayments, however at the 8th December they have £1.9 million available. As long as they can keep up with the repayments they will not have to do a fund raise. If they can't then they will have to come to the market.

The way they have described the interest rate calculation is exactly how I would expect them to. I suspect that the margin spread range of 2.4 - 3.15% is the difference between the loan and the revolving credit facility. The effective rate of 8.3% will be the WACC across both facilities.

The write off should actully have a positive impact on the cashflow as it should create a corporation tax asset so no tax payments for a while and could even be a rebate.

Sales are vanity, profit is sanity and cash is reality.

adeg
Chat Pages: 62  61  60  59  58  57  56  55  54  53  52  51  Older

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com